Revvity, Inc. (RVTY)
(Real Time Quote from BATS)
$109.74 USD
+1.59 (1.47%)
Updated Jul 22, 2024 03:05 PM ET
4-Sell of 5 4
C Value D Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
RVTY 109.74 +1.59(1.47%)
Will RVTY be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for RVTY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RVTY
Analysts Estimate Revvity (RVTY) to Report a Decline in Earnings: What to Look Out for
Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?
RVTY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Reasons to Retain Revvity (RVTY) Stock in Your Portfolio Now
Why Is Pediatrix Medical Group (MD) Down 15.9% Since Last Earnings Report?
Cencora (COR) Down 1.9% Since Last Earnings Report: Can It Rebound?
Other News for RVTY
Ex-Dividend Reminder: Revvity, Patterson Companies and First Busey
NIH outlays rise by 5% in June, says Baird
Revvity To Hold Earnings Call on Monday, July 29, 2024
Barclays Sticks to Their Hold Rating for Revvity (RVTY)
Revvity price target lowered by $1 at Barclays, here's why